Rituximab as first‐line adjuvant therapy for pemphigus: Retrospective analysis of long‐term outcomes at a single center
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2017.11.024
Abstract: Supported through the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), and the NIH Medical Research Scholars Program, a publicprivate partnership supported jointly by… read more here.
Keywords: rituximab first; therapy pemphigus; research; first line ... See more keywords